
DNA P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.99
Average-0.8615
Median-0.8350
Minimum-1.09
Maximum-0.7600
-0.99
Past Month-0.14 (16.47%)
The P/E ratio for DNA is -0.99 as of Jun 13, 2025. This represents a increase of 47.76% compared to its 12-month average P/E ratio of -0.67. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Ginkgo Bioworks Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Ginkgo Bioworks Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Ginkgo Bioworks Holdings to industry peers.
Ginkgo Bioworks Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Ginkgo Bioworks Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Ginkgo Bioworks Holdings to industry peers.
DNA P/E Ratio Insights
See Ginkgo Bioworks Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in DNA
Order type
Buy in
Order amount
Est. shares
0 shares
DNA P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $7.13 | -0.79 |
May 1, 2025 | $6.96 | -0.66 |
Apr 1, 2025 | $5.66 | -0.53 |
Mar 3, 2025 | $8.01 | -0.75 |
Feb 3, 2025 | $12.85 | -1.00 |
Jan 2, 2025 | $10.22 | -0.79 |
DNA End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.99 | +30.26% |
2024 | -0.76 | -79.89% |
2023 | -3.78 | +390.91% |
2022 | -0.77 | -85.82% |
2021 | -5.43 | — |
FAQs About Ginkgo Bioworks Holdings (DNA) P/E ratio
The latest P/E ratio of DNA is -0.99, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Ginkgo Bioworks Holdings’s last 12-month average P/E ratio is -0.67, compared to its current P/E ratio of -0.99. This reflects a increase of 47.76%.
Ginkgo Bioworks Holdings’s current P/E ratio of -0.99 is higher than its last 12-month average P/E of -0.67. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Ginkgo Bioworks Holdings’s average P/E ratio over the last 3 years is -1.61. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Ginkgo Bioworks Holdings’s average P/E ratio over the last 5 years is -3.77. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.